FDA Pulmonary/Rheumatology Division Sees Management Shakeup

Deputy Director for Safety Sally Seymour will become interim director of US FDA's Pulmonary, Allergy and Rheumatology Products Division following departure of  division's top two managers, Badrul Chowdhury and Lydia Gilbert McClain.

FDA entrance sign 2016

More from US FDA

More from Agency Leadership